Skip to main content

Rapid pace of interceptor and precision-guided weapons use worries Trump admin.

▶ Watch Video: U.S. bolsters military in Middle East amid 12th night of strikes on Iran

Washington — The rapid pace at which the U.S. is expending some of its most advanced air-defense interceptors and precision-guided weapons in the Middle East is a point of great tension inside the Trump administration as President Trump’s war with Iran ratchets up again, according to U.S. military and intelligence officials familiar with internal assessments. And it’s raising broader concerns about America’s readiness for a potential conflict in the Indo-Pacific. 

The dwindling stockpiles of defensive interceptors and long-range missiles have become a pressure point for top military and civilian leaders who are weighing the demands of the war with Iran against maintaining readiness to deter other adversaries, including China. 

The U.S. officials, who spoke to CBS News on condition of anonymity given the sensitivity of the topic, said the U.S. cannot sustain the rate at which it expended precision munitions early in the campaign against Iran.

The defense industrial base is not equipped to produce missiles rapidly enough to replenish munitions that have been fired or transferred to U.S. Central Command, which is overseeing the conflict, leaving inventories under mounting pressure even as military operations continue. 

Interceptors are in heavy use to defend U.S. interests in the Gulf states, which house U.S. troops and are being targeted by Iranian drones and missiles.

One partner country told CBS News there is a need for a pause in fighting, particularly given the intensity of Iranian strikes that have been battering Kuwait and Bahrain. Kuwait said earlier this week that Iran struck its infrastructure, damaging electricity and desalination plants

In an interview last month with “Face the Nation with Margaret Brennan,” Defense Secretary Pete Hegseth denied that there was any crisis with the stockpiles. He conceded that some munitions may take more time to produce than others, but he told Brennan, “We’ve got lots of them, we’re building more than ever before.”

“Our stockpiles are strong, and they will only get stronger in the future,” Hegseth said.

But U.S. commanders have increasingly been shifting toward using more GPS-guided bombs fitted with Joint Direct Attack Munitions, or JDAM, guidance kits, along with Small Diameter Bombs, which are precision-glide weapons that can attack fixed targets at shorter ranges and can also be used in lieu of long-range standoff weapons. 

Earlier in the conflict, U.S. forces frequently employed long-range cruise missiles such as the Joint Air-to-Surface Standoff Missile, known as JASSM, and the Tomahawk Land Attack Missile. Those weapons remain in the arsenal, officials said, but are being used more sparingly. 

In April, Adm. Samuel Paparo, the head of U.S. Indo-Pacific Command, told lawmakers on Capitol Hill that scaling up output of high-end systems such as the Tomahawk cruise missile or JASSM could take years, as defense companies work on expanding production lines. 

“I think it will take one to two years for them to scale,” said Paparo, whose responsibilities include preparing for any potential conflict in the Pacific region, including with China. “It won’t be soon enough. There are finite limits to the magazine, and I have all the faith in the world that they’re being employed judiciously.” 

Following the collapse of the ceasefire earlier this month, U.S. strikes have focused on targets closer to Iran’s coastline, reducing the need for aircraft to penetrate deeper into Iranian territory, where they would face denser air-defense networks and a greater threat from surface-to-air missiles. 

The U.S. officials told CBS News there are limited inventories of the Army Tactical Missile System, or ATACMS, the long-range missiles fired from the High Mobility Artillery Rocket System, known as HIMARS, a truck-mounted launcher capable of firing precision rockets and missiles. 

Concerns over certain munition inventories are not new. The Biden administration delayed giving ATACMS to Ukraine in part because drawing from those inventories could undermine U.S. military readiness, CBS News previously reported. 

The U.S. has comparatively healthier supplies of the shorter-range Guided Multiple Launch Rocket System, or GMLRS, which is also fired from the HIMARS launcher, the officials told CBS News, allowing commanders greater flexibility for targets within its range.

The most pressing concern involves air-defense interceptors, used to defend against cruise and ballistic missiles, aircraft and lethal drones, several sources said.

The U.S. has expended large numbers of Patriot and Terminal High Altitude Area Defense, or THAAD, interceptors to defend against both ballistic missiles and drones, consuming inventories faster than industry can replace them.

To support operations in the Middle East, the Pentagon has shifted interceptor inventories from other regions, including stocks that had been prepositioned for the Indo-Pacific. Those transfers have left other combatant commands operating with thinner margins than military planners consider ideal, particularly as the U.S. seeks to deter Chinese military action around Taiwan and reassure allies across the Pacific. 

Asked for comment, chief Pentagon spokesman Sean Parnell told CBS News: “America’s military is the most powerful in the world and has everything it needs to execute at the time and place of the President’s choosing. We have executed multiple successful operations across combatant commands while ensuring the U.S. military possesses a deep arsenal of capabilities to protect our people and our interests.”

In 2022, Elbridge Colby, who was a defense official during the first Trump administration and is now the undersecretary for policy at the Pentagon, summed up the choices confronting an American military stretched across the globe: “A missile used in Europe can’t be used in Asia,” he wrote in Time magazine.

He was commenting on the use of U.S. munitions in the war in Ukraine. But the latest stage of the American campaign against Iran has brought the same strategic dilemma into renewed focus.

A year later, Colby argued that weapons that could be useful for defeating a Chinese attack along the first island chain — a string of islands off China’s coast extending from Japan, through Taiwan and the Philippines — should be reserved for that purpose. The concerns of U.S. officials about current stockpiles involve some of those same weapons.

During the ceasefire pause, a Center for Strategic and International Studies report said more than 1,000 Tomahawks and 1,100 JASSMs had been used and that replacement timelines were approaching four years. It said that supplies of air-defense interceptors are under even greater strain, as the U.S. burns through a significant share of prewar inventories of THAAD, SM-3 missiles and Patriots. These weapons face production timelines of up to five years. 

Taken together, the numbers suggest that the central problem is not simply cost but time. Many of the weapons being fired in weeks or months cannot be replaced for years

US measles cases surpass 2,000 for the 2nd year in a row: CDC

Human crowd surrounding an injectable measles vaccine bottle on purple background. Horizontal composition with copy space. ( MicroStockHub/Getty Images)(NEW YORK) -- Measles cases in the United States have surpassed 2,000 for the second year in a row, according to data updated Friday from the Centers for Disease Control and Prevention (CDC).So far in 2026, 2,030 confirmed cases have been recorded in 38 states and the District of Columbia, CDC data shows.Cases have been confirmed in: Alaska, Arizona, California, Colorado, Florida, Georgia, Idaho, Illinois, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nebraska, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Texas, Utah, Vermont, Virginia, Washington, Wisconsin and Wyoming.Just 10 measles cases were reported among international travelers so far this year, according to CDC data.Last year, 2,288 confirmed measles cases were reported for all of 2025. Prior to this, measles cases had not surpassed 2,000 in the U.S. since 1992.The U.S. also saw its first measles deaths in more than a decade last year, including two among unvaccinated school-aged children in Texas and one among an unvaccinated adult in New Mexico.The majority of measles cases in 2026 have been confirmed among children and teenagers aged 19 and younger, according to the CDC.About 92% of cases are among people who are unvaccinated or whose vaccination status is unknown, CDC data shows.Meanwhile, 4% of cases are among those who have received just one dose of the measles, mumps, rubella (MMR) vaccine and 4% of cases are among those who received the recommended two doses, according to the CDC.Dr. William Schaffner, a professor of preventive medicine at Vanderbilt University Medical Center in Nashville, referred to the latest figures as "very disappointing and very concerning.""It indicates that an increasing number of parents are either postponing or withholding their children from vaccination, and this is very concerning because it permits this virus back now into in the United States to continue to spread and obviously to cause illness in the children affected," he told ABC News.January 2026 marked one year since measles cases were first detected on Texas. It’s unclear if the cases confirmed on Jan. 20, 2025, are linked to those that have been found other states; if so, it would mean the U.S. has seen a year of continuous transmission.If it's determined that the U.S. has experienced 12 months of continuous measles transmission, it could lead to a loss of the country's elimination status that was earned in 2000. Measles would once again be considered endemic or constantly circulating.The review of the measles elimination status in the U.S., which is determined by the Pan-American Health Organization, will take place in November 2026.Schaffner said the U.S.'s measles elimination status is threatened as a result of so many cases."Measles, because it's the most contagious virus, is like the canary in the coal mine; it's the alert that lets us know that we're also opening ourselves up to other transmissible diseases that vaccines could prevent," he said.The CDC currently recommends that people receive two doses of the MMR vaccine, the first at ages 12 to 15 months and the second between 4 and 6 years old. One dose is 93% effective, and two doses are 97% effective against measles, the CDC says.However, CDC data show vaccination rates have been lagging in recent years. During the 2024 to 2025 school year, 92.5% of kindergartners received the MMR vaccine, according to data. This is lower than the 92.7% seen the previous school year and the 95.2% seen in the 2019 to 2020 school year, prior to the COVID-19 pandemic.Schaffner said that public health specialists need to listen carefully to parents who are skeptical or hesitant of getting their children vaccinated."Have them speak to their own family doctors and pediatricians, have those conversations, and our pediatricians and family doctors have to provide a level of comfort and reassurance," he said. "Facts are fundamental, but more importantly, these parents need reassurance and a level of comfort that what their doctors ... are recommending is in the best interest of their child and the communities in which their children live.""These diseases are bad and can be really bad. The vaccines are good and really good," Schaffner added.Copyright © 2026, ABC Audio. All rights reserved.
Read Next Story